Clinitech Laboratory Ltd

The next results date for Clinitech Lab is 12 November 2025.

As of 28-Oct, Clinitech Laboratory Ltd's stock price is Rs 42.52, up 4.99% over three days but down 46.08% year-to-date. Despite a recent increase, the stock has underperformed compared to the Sensex, which has risen 8.30% this year.

As of 08-Oct, Clinitech Laboratory Ltd's stock price is Rs 41.71, down 4.99%, and has underperformed its sector by 5.01%. The stock shows a bearish trend, trading below all key moving averages, with a significant decline in delivery volume and a year-to-date drop of 47.11% compared to the Sensex's 4.65% increase.

As of 26-Sep, Clinitech Laboratory Ltd's stock is priced at Rs 46.20, up 5.0% today, but has declined 7.60% over the past month and 41.42% year-to-date. Despite short-term gains, the overall trend remains negative compared to the benchmark Sensex.

As of 24-Sep, Clinitech Laboratory Ltd's stock price is at 44.00, down 1.79%, and has significantly underperformed its sector and the broader market, with a year-to-date decline of 44.20%. The stock's erratic trading and decreased delivery volume indicate falling investor confidence.

As of 19-Sep, Clinitech Laboratory Ltd's stock price is Rs 44.80, down 2.69% today and 43.19% year-to-date, significantly underperforming the benchmark Sensex, which has increased by 5.74%. The stock shows mixed signals, trading above its 50-day moving average but below shorter-term averages, with a sharp decline in delivery volume indicating reduced investor interest.

As of 17-Sep, Clinitech Laboratory Ltd is priced at 46.04 with no change in price. The stock has underperformed significantly, declining 41.62% year-to-date, and has seen a 9.73% drop over the past week, indicating a bearish trend and reduced investor participation.

As of 15-Sep, Clinitech Laboratory Ltd's stock price is at 46.04, unchanged, with a significant decline of 15.52% over the past week and 41.62% year-to-date. The stock is underperforming compared to the broader market, reflecting negative investor sentiment and decreased participation.

As of 12-Sep, Clinitech Laboratory Ltd's stock is priced at Rs 46.04, down 4.99%, and has lost 15.52% over the last four days. The stock has significantly underperformed the market, with a year-to-date decline of 41.62%, indicating ongoing challenges for the company.

As of 11-Sep, Clinitech Laboratory Ltd's stock price is Rs 48.46, down 4.98% and has fallen 11.08% over the last three days. The stock has significantly underperformed year-to-date and over the past year, with a sharp decline in delivery volume indicating reduced investor interest.

As of 10-Sep, Clinitech Laboratory Ltd is priced at 51.00, down 1.51% and has declined 6.42% over the last two days. Despite a recent uptick in short-term returns, the stock has significantly underperformed year-to-date, with a decline of 35.33% compared to the Sensex's gain of 4.21%.

As of 09-Sep, Clinitech Laboratory Ltd's stock price is Rs 51.78, down 4.99% today and underperforming its sector. Despite a 6.08% gain over the past week and increased investor participation, the stock has a year-to-date decline of 34.34%, contrasting with the Sensex's positive performance.

As of 08-Sep, Clinitech Laboratory Ltd's stock price is Rs 54.50, up 4.07% over three days with an 11.66% total return, outperforming its sector. However, investor participation has declined significantly, with delivery volume down 76.19% from the 5-day average, and the stock remains down 30.89% year-to-date.

As of 05-Sep, Clinitech Laboratory Ltd's stock is priced at Rs 52.37, having increased by 2.69% recently, but it has underperformed over the past week and year-to-date with declines of 0.25% and 33.59%. The significant drop in delivery volume suggests reduced investor interest, complicating the stock's recovery prospects despite a short-term gain.

As of 04-Sep, Clinitech Laboratory Ltd's stock price is Rs 51.00, up 4.49% today, but it has declined 35.33% year-to-date. Despite recent short-term gains, the stock faces challenges due to erratic trading and reduced investor participation.

As of 02-Sep, Clinitech Laboratory Ltd's stock price is Rs 48.81, down 7.45% and underperforming its sector. The stock has declined 38.11% year-to-date, contrasting sharply with the Sensex's 2.58% gain during the same period.

As of 01-Sep, Clinitech Laboratory Ltd's stock is priced at 52.74, having increased by 0.46% recently. Despite a short-term gain, the stock has significantly underperformed over the year, with a 33.12% year-to-date decline, and shows mixed signals regarding price momentum and investor participation.

As of 29-Aug, Clinitech Laboratory Ltd's stock price is Rs 52.50, up 5.0% today, but concerns about erratic trading and a 92.42% drop in delivery volume raise questions about sustained growth despite recent short-term gains. Year-to-date and yearly returns remain negative compared to the broader market.

As of August 28, 2025, Clinitech Lab is considered undervalued with a PE ratio of 11.41 and a low PEG ratio of 0.00, indicating a positive shift in its valuation grade to attractive, despite a year-to-date return of -36.6%, while outperforming the Sensex over the past month.